| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  CardioScale Ltd. CardioScale is an Israeli medical device start-up founded 2012, pursuing a novel patent applied diagnostic for early detection of cardiovascular deterioration in various patients of heart failure and shock. Type: | 0 | 0 | 0 | 1 |
 |  Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: | 5 | 2 | 0 | 34 |
 | BRAINCURES Powering a drug discovery revolution to deliver cures for brain diseases that affect at least 1 in 10 people worldwide Brain diseases have no cures and affect 1 in 10 people worldwide and their families. BRAINCURES aims to tackle brain diseases with precision medicine based on the code for brain function. Our landmark decoding of the molecular framework behind brain health pinpointed SMART Target-Biology linkages that now empower novel translational avenues to conquer brain diseases through SMART Patient Stratification and SMART Treatments. The application of our proprietary platform technologies will lead to personalized treatments for the 350 million people worldwide … Type: | 0 | 0 | 0 | 2 |
 | Alternative Plants Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming Type: | 4 | 2 | 2 | 10 |
 |  Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: | 1 | 0 | 1 | 85 |
 | String Bio Private Limited String Bio enables Next Generation Ingredients that are sustainable and traceable for evolving value chains. String’s purpose is to commercialize next generation ingredients that enable sustainability and traceability in evolving value chains. String Bio is in the business of manufacturing raw materials for Animal Nutrition, Agriculture, Human Nutrition and Personal Care sectors that are derived using a sustainable and traceable process. String, as one of the world leaders in gas fermentation, has a strong IP protected platform called SIMP (String Integrated Methane Platform) that enables production of high quality ingredients using methane. Our proprietary platform leverages advances in synthetic biology, … Type: | 1 | 1 | 0 | 88 |
 | MaxBionic We develop prosthetic technologies transforming the market. Our goal is to help rehabilitate after amputation using technology. Solutions are available for those who have suffered amputation of the upper extremities. MaxBionic is a young company specializing in prosthetics that drastically transforms the market through its technologies. At present, one can choose from available products for use after upper limb amputation. Our task is to increase, by using the latest technologies, the rehabilitation efficiency in people after amputation. Robotic, Medicine, Prosthetic, Rheabilitation, and manufacture Type: | 0 | 0 | 0 | 3 |
 | Protilab [Automatic translation follows] Creator of smiles for all Created in 2006, Protilab is the only ISO certified dental prosthesis laboratory in its sector. The work is carried out in its ultra-modern dental prosthesis laboratory certified ISO 9001:2008 and ISO 13485:2003. Protilab has, in its Parisian premises, a fully equipped laboratory allowing the execution and repair of all express work. Protilab offers 5 quality commitments: • Certification • Materials • Traceability • Follow up • Guarantee dental prosthesis laboratory, joint prostheses, assistant prostheses, CAD/CAM, digital impression management, and prostheses on implants Type: | 0 | 0 | 0 | 37 |
 | Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: | 13 | 10 | 4 | 12 |
 | Organovo Holdings, Inc. Discovering drugs using highly customized human tissues as living, dynamic models of human biology and disease. We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com. 3D bioprinting, 3D printing, Drug discovery and … Type: | 0 | 0 | 0 | 35 |
 | Isomab Ltd IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease. Type: | 0 | 0 | 0 | 13 |
 | TruSpine Technologies plc Preserving Natures Design TRUSPINE TECHNOLOGIES LIMITED is a medical device company focused on developing uniquely disruptive technologies to revolutionise the spinal stabilisation market, commencing with three flagship pioneering devices. The Cervi-LOKTM (for the cervical and upper thoracic spine), GRASP Laminoplasty (a treatment for decompression of the spinal cord) & Faci-LOKTM (for the lumbar and lower thoracic spine). These unique devices represent a paradigm shift in spinal fixation, by providing exceptional stabilisation while not altering the bony anatomy unlike screws, staples or other devices which currently dominate the spinal market. Medical Devices, Medical research, Orthopedics, and Spinal stabilisation Type: | 0 | 0 | 0 | 3 |
 | PetMedix R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK The PetMedix channel will soon be discontinued as we join forces with Zoetis. Follow the Zoetis channels to stay connected and for the latest updates! Biotechnology, Drug Development, Drug Discovery, Therapeutic Antibodies, Monoclonal Antibodies, Companion Animal, Veterinary Medicine, and Research and Development Type: | 6 | 0 | 5 | 16 |
 |  AIOVA [Automatic translation follows] Vaccines for the future Based on innovative, patented technology, AIOVA aims to develop and market innovative vaccines with high added value to its pharmaceutical industrial clients. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics of humans and animals, in a OneHealth approach, and in particular influenza (human and avian influenza), AIDS-type diseases, and, very recently , diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed using a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production … Type: | 0 | 0 | 0 | 1 |
 | LABORATOIRES CRYOBEAUTY PHARMA [Automatic translation follows] Permanently eliminates brown spots in just one application! Our company specializes in the research, development and fine-tuning of medical devices in dermatology and dermo-cosmetics using cutting-edge technology, unique in the world. This is Cyto-Selective Cryotherapy. This breakthrough technology is patented. It benefits from numerous competitive barriers. Cyto-Selective Cryotherapy consists of acting on the skin with controlled and perfectly controlled cold to target, for the first time, only cells according to their sensitivity and viability to temperature variations with extreme precision without affecting all the other cells of the skin. skin. After many years of research, we have … Type: | 0 | 0 | 0 | 1 |
 | NEOSTEO SIMPLE CREATIVE SOLUTIONS NEOSTEO is a smart innovative startup company specialized in the development, production and marketing of advanced implants solutions aimed to simplify orthopedic and trauma surgery. With over 15 years of experience and a state of the art production line, NEOSTEO’s team offer a comprehensive range of Knee Osteotomy Implants Solutions as well as a wide range of solutions for Forefoot surgery. The company's products are being distributed around Europe countries through its experimented global distribution network. NEOSTEO' Surgeons Advisory Board and engineers are committed to continuous research and development of new progressive products and technologies to support … Type: | 1 | 1 | 0 | 6 |
 | ALBHADES [Automatic translation follows] Analytical Solutions for Health Products 💊💉 Expert in microbiology and physico-chemistry, Albades has been supporting the health product industries (pharmaceuticals, medical devices, cosmetics), the chemical and food industries since 2001. Its analytical capabilities combined with its consulting service offer a global solution to the needs of method development and validation, process validation and quality control of raw materials, finished products and packaging. Its multiple combination of expertise positions Albhades with a complete analytical offering including inorganic chemistry, organic chemistry, NMR analyses, microbiology, cellular biology, mechanical testing, stability studies and toxicology. Its strength lies in the personalized support … Type: | 6 | 1 | 3 | 76 |
 | AveXis, Inc. AveXis is now Novartis Gene Therapies Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA). Follow us on LinkedIn: https://www.linkedin.com/company/novartis-gene-therapies/ How to reach us: Novartis Gene Therapies 2275 Half Day Road, Suite 200 Bannockburn, IL 60015 Email: gtx.communications@novartis.com Office Phone: 847.572.8280 Toll-free Phone: 844.428.3947 Gene Therapy, Synthetic Biology, and Spinal Muscular Atrophy Type: | 1 | 0 | 0 | 107 |
 | Cell-Free Technology Ltd. We build biocomputers. We are hiring. Type: | 1 | 0 | 0 | 0 |
 | VoltSafe Inc. A safer, simpler and smarter way to connect and control electricity. unplug. connect. At VoltSafe, we're fearless creators, obsessed with progress. Our products are unique and our technology is revolutionary in the field of electronics. And while everyone is infatuated with innovations at one end of the power cord, we’re obsessed with improving the other end to change how people connect to power. Simply put, we’ve discovered a smarter and safer way to connect to electricity using magnets. Importantly, our patented technology empowers retail producers, industries, governments and essential services to do their jobs more safely, efficiently and sustainably. Our … Type: | 1 | 0 | 1 | 21 |
 | LYSOGENE Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early … Type: | 7 | 5 | 0 | 10 |
 | EverImmune Harnessing the microbiome for the development of diagnosis and therapeutic tools in cancer ! EverImmune is a biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology. It harnesses the gut microbiota for the development of a unique approach aiming to restore the response of Immune Checkpoint Inhibitors (ICIs) in cancer patients. The company is developing Oncobax AK, a Live Biotherapeutic Product (LBP) used as an oral adjuvant to anticancer immunotherapies, designed to safely boost the immune system and restore sensitivity to immunotherapies in primary resistance settings. The company also develops other bacteria in … Type: | 2 | 0 | 2 | 3 |
 | Stellate Therapeutics Stellate Therapeutics develops innovative microbiome-derived small molecules to treat neurodegenerative diseases. Stellate Therapeutics is a pre-clinical stage start-up company developing innovative microbiome-derived small molecules to treat neurodegenerative diseases. We utilize the microbiome for our drug portfolio and our research focuses on the gut-brain axis. Due to millions of years of co-evolution, complex metabolic interactions exist between humans and their gut bacteria and Stellate has uncovered a unique set of metabolites that are produced by the microbiome and are involved in the maintenance of health. Our first drug will be a treatment for Parkinson’s disease. Type: | 0 | 0 | 0 | 9 |
 | NVH Medicinal [Automatic translation follows] The synthetic collagen revolution NVH Medicinal, world expert in synthetic collagen NVH Medicinal is a biotechnology company based in Dijon, created at the end of 2008, whose mission is to treat pathologies linked to a collagen deficiency. It develops products derived from collagen, the most abundant protein in the body and whose dysfunctions cause many diseases (aging, cardiovascular, inflammatory, neurological diseases, fibrosis, cancer and rare diseases). NVH's ambition is to be recognized as an innovative player in the treatment of collagen-related diseases by becoming one of the world leaders in the development, production and marketing of a … Type: | 0 | 0 | 0 | 3 |
 | WestStar Precision Inc Best practice manufacturing of your design in metal or plastic. CNC machining and assembly to meet critical needs. WestStar Precision is an international strategic outsourcing partner of specialized machined components and assemblies ultimately incorporated into the market leading aerospace vessels and innovative medical devices. WestStar Precision specializes in early supplier involvement support and supplying aircraft structural components, aircraft interior (structural and cosmetic) for the top aerospace industry OEM brands as well as their respective Tier 1, Tier 2, and Tier 3 suppliers. WestStar Precision is proud to be a trusted partner to today's most innovative medical device manufacturers by providing … Type: | 0 | 0 | 0 | 14 |
 | FUJIFILM Cellular Dynamics, Inc The Power of Human Biology: Leveraging our human iPSC technology to revolutionize scientific research and cell therapy. Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development. induced pluripotent stem cells (iPS cells), human tissue cells, cardiomyocytes, endothelial cells, custom iPS cell lines, neurons, dopaminergic neurons, skeletal myoblasts, hepatocytes, hematopoietic progenitor cells, cardiac progenitor cells, and astrocytes Type: | 5 | 1 | 3 | 213 |
 | Dosepharma [Automatic translation follows] Dosepharma, the blistering service provider for pharmacists. Founded in 2013, Dosepharma specializes in the packaging of medicines (Blistering). Certified by Swissmedic, our company stands out for offering personalized, high-quality Blistering services. In our laboratory, doses of personalized medications are placed in blister packs in a robotic, highly controlled manner and in accordance with the highest safety standards. We work on a daily basis to relieve patients in their medication intake and allow pharmacists to benefit from a tailor-made service for their patients. Technology, Automation, Medicine, Digital, Pharmacy, IT, challenger mindset, and unit sales Type: | 0 | 0 | 0 | 9 |
 | AYOXXA Biosystems GmbH AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics … Type: | 0 | 0 | 0 | 23 |
 | RayBiotech #Biotech company offering #proteomics detection tools since 2001. #Research news, promos, & blogs. #Biomarkers #CRO RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service. Protein Immunoassays, ELISA Kits, Antibody Arrays, Glycoscience, Protein Arrays, Immunological Assays, Antibody Development, Assay Development, Custom Protein Expression, Statistical Analysis, CRO Services, Flow cytometry, Recombinant proteins, Aptamers, Phosphorylation, Biostatistics, and Bioinformatics Type: | 0 | 0 | 0 | 61 |
 | Regenosine Harnessing the healing potential of adenosine for tissue regeneration Privately held company focused on developing and marketing first-in-class regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing potential of the purinergic system which plays a critical role in maintaining cartilage homeostasis. Our lead product is a proprietary formulation for regenerating cartilage in joints with established osteoarthritis, targeting a rapidly growing joint preservation market. Our goal is to offer patients a disease modifying therapy with uncompromising efficacy relative to existing technologies. By developing this disease modifying therapy, we will significantly improve clinical outcomes and patient quality of life, and … Type: | 0 | 0 | 0 | 2 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: | 0 | 0 | 0 | 1 |
 | Nano3D Biosciences Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and … Type: | 1 | 0 | 0 | 1 |
 | StemTek Therapeutics StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells. Type: | 0 | 0 | 0 | 1 |
 | Medica Media Medica Media provides print, web-based and mobile media solutions for medical professionals. Written by doctors for doctors. Makers of PocketDr. PocketDr is the must-have app for all junior doctors with on-call responsibilities. It is an aide-memoire for the things you know - but may not recall quickly in the dead of night with constant bleeps and distractions. Succinct. Pre-digested info. When you need it. Contents include: - Checklists for assessment of the deteriorating patient. Be prepared for any NEWS call: Hypoxia, Tachycardia, Hypotension, low GCS. - Checklists for management of 21 acute medical conditions including: ACS, AF, Asthma, Delerium, Hyperkalaemia, … Type: | 10 | 2 | 9 | 1 |
 | Desktop Genetics Powering the genome editing revolution with AI-driven design and analysis for cell therapy and drug discovery. Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library … Type: | 0 | 0 | 0 | 0 |
 | Surface Oncology Inc. #lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021 Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies … Type: | 2 | 1 | 0 | 23 |
 | Teva Santé [Automatic translation follows] Who is Teva Health? Present in more than 60 countries, the leading producer of active ingredients for the pharmaceutical industry, Teva is one of the largest pharmaceutical laboratories in the world. Its range of medicines, generic or not, allows the treatment of more than 120 pathologies. In France, its medications concern one in 12 prescriptions. But Teva's involvement goes well beyond just medicine. Its action is part of commitments in favor of patients, doctors, pharmacists and caregivers. With regard to the latter, the laboratory is particularly committed to helping them identify themselves, understand and master their role, … Type: | 12 | 1 | 9 | 261 |
 | MyCognition Changing the world one mind at a time MyCognition has developed NHS approved apps that assess and promote brain health through cognitive fitness. The apps are CE Marked (class 1A medical device) and recently we obtained a prestigious UCL award for our research. Our apps work on all devices, in all settings, are self-administrated and provide insightful reports and automatically assess to personalise cognitive training. They work in people of all ages, gender and health states. MyCognition enhances brain health and performance through the use of our cognitive fitness assessment and training programmes, which are self-administered, easy to access and … Type: | 0 | 0 | 0 | 1 |
 | Open Bionics Turning disabilities into superpowers Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. We've started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. We're on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the … Type: | 2 | 1 | 1 | 52 |
 | Humanigen, Inc. Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralization and gene-knockout platforms. Its proprietary Humaneered® monoclonal antibodies, designed to optimize antibody properties, show promise in prevention/treatment of cytokine storm induced by SARS-CoV-2 (COVID-19), chimeric antigen receptor T-cell (CAR-T) therapy and graft versus host disease (GvHD) by neutralizing GM-CSF which is up-regulated in these conditions. Type: | 0 | 0 | 0 | 7 |
 | ImmunXperts, a Q2 Solutions Company Your partner in immunology projects! ImmunXperts a Q2 Solutions Company, your partner for what’s next in assay and biomarker development, advanced laboratory testing, and translational immunology. ImmunXperts brings an unrivaled ability to efficiently develop immunogenicity and immuno-oncology in vitro assays – to address both wanted and unwanted immunity for novel modalities. Immunogenicity Assessment, Immune Academy, Training, Consultancy, immuno-oncology, Cell Therapy, In vitro, assay development, Primary cells, Immunogenicity, and Immunology Type: | 1 | 0 | 0 | 27 |
 | Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 1 | 1 | 0 | 39 |
 | EOFlow A South Korea-based medical devices company that offers innovative technology to streamline diabetes care management EOPatch(Wearable Insulin Pump) Manufacturer Type: | 1 | 1 | 0 | 3 |
 | La Jolla Institute for Immunology Dedicated to understanding the intricacies and power of the immune system; striving toward a Life Without Disease ®. "Sometimes in science there are so many people trying to answer the same question that it's good to stray off in another direction," Mitchell Kronenberg, Ph.D., LJI Professor. "Taking the road less traveled can bring its voyagers to unexpected - and even groundbreaking - new territory." The La Jolla Institute The La Jolla Institute for Immunology is a non-profit medical research institute dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand … Type: | 1 | 0 | 1 | 427 |
 | Groupe d'Étude et de Promotion des Protéines Végétales [Automatic translation follows] Long live plant proteins! The GEPV, with the support of interprofessional organizations, supports the development of plant proteins by actively participating in a better knowledge of these products. VPMs (plant protein materials) are food ingredients derived from protein-rich plant species, such as legume seeds (soybean, udder, lupine, faba bean) and cereal seeds (wheat). Type: | 5 | 1 | 5 | N/A |
 | Synthesea Building a biological platform to produce low-cost, sustainable omega-3 for aquaculture. Powered by Synthetic Biology. Powered by Synthetic Biology, Synthesea is developing synthesis technology that is transferable to a wide range of lipids (AKA fats). And we're starting with omega-3. Omega-3 oil is a necessity for fish to grow nutritiously and is naturally found in algae, which wild fish eat. Fish grown in aquaculture (farms for fish livestock) cannot eat algae due to scaling limitations. Therefore, the current solution is to feed wild-caught fishmeal (crushed fish) to aquaculture fish. This rapidly depletes wild fish stocks and is continuously increasing the … Type: | 0 | 0 | 0 | 1 |
 | Nextbiotics Nextbiotics, engineering viruses for good. Biotech, CRISPR, and Digital Biology Type: | 0 | 0 | 0 | 3 |
 | Next Big Innovation Labs® Next Big Innovation Labs® is a Deep Tech Lifesciences platform, developing 3D Bioprinting Technology and Products Next Big Innovations Labs (NBIL) is a startup of enthusiastic individuals on a mission to confront the world’s most challenging problems in the healthcare space. We are a research driven startup working on a novel approach to tackle the current muddle vexing the pharmaceutical, clinical and cosmetic R&D sectors. We feel we can crack these problems only by using the disruptive technology of 3D Bioprinting. At NBIL, we focus to solve the organ availability crisis plaguing the entire globe using 3D Bioprinting; aiming to … Type: | 2 | 0 | 2 | 30 |
 | iPC H2020 Giving clinicians the tools and knowledge to create individualized treatment plans for their paediatric cancer patients. Cancer in children is rare but when it happens, clinician prescribed treatment options are not always as clear as one would hope. In fact, on average, only a quarter of oncology patients respond to the drug therapy they receive. There are many reasons for this but evidence shows that a personalized treatment plan or treatment that is based on the patient's fundamental biology could significantly enhance treatment outcomes. As it turns out, the personalized treatment plan can be as complex as the cancer itself … Type: | 2 | 0 | 2 | 0 |
 | AbiliLife Join us on our mission to reduce back injuries and create a safer workforce with the Calibrace+ back brace. AbiliLife is a leading medical technology company transforming how people manage their mobility and balance challenges. Our innovative products are designed to enhance the quality of life and empower individuals to live independently and pain-free. Our flagship product, the Calibrace+, is a unique back brace that provides targeted support to the trunk and helps improve posture and balance. The Calibrace+ is a game-changer for workforces. Back injuries and pain are common problems in many industries, reducing productivity, absenteeism, and healthcare costs. … Type: | 0 | 0 | 0 | 1 |
 | Zealand Pharma Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on … Type: | 3 | 1 | 2 | 336 |
 | Epizyme On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of … Type: | 3 | 0 | 2 | 99 |
 | H3 Biomedicine Human. Health. Hope. H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of genetically defined patient populations. H3 has leveraged its integrated expertise in genomics, tumor biology, bioinformatics and innovative synthetic organic chemistry to create an integrated drug development ecosystem to deliver patient-based, genomics-driven, small molecule drugs. In less than three years, H3 has developed four discovery platforms, which have produced two drug candidates for which the company expects to file investigational new drug (IND) applications in late 2015. Founded by a $200 million dollar … Type: | 2 | 0 | 1 | 38 |
 | Medical Optometry America MOA helps preserve the beauty of sight by expanding access to high-quality medical eye care. Medical Optometry America (MOA) helps preserve the beauty of sight by expanding access to high-quality medical eye care. Our medical optometrists have received extensive additional training and are committed to excellence in visual and ocular health. Their experience, supported by the advanced technology available at the MOA Diagnostic and Therapeutic Center, enables them to provide exceptional patient outcomes. With Medical Optometry America, you get the best of today’s leading medical science with personalized care from our primary eye care doctors. Medical Optometry, Medical Eye Care, … Type: | 0 | 0 | 0 | 16 |
 | Magenta Therapeutics Developing novel medicines to bring the curative power of stem cell transplants to more patients Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients. Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com. Follow Magenta on Twitter: @magentatx. Hematopoietic Stem Cell … Type: | 3 | 2 | 1 | 62 |
 | BrainXchange Your source for all things XR, digital twins, AI, and emerging tech in enterprise BrainXchange is a world-class conference organizer and thought leader in the enterprise AR/VR/MR (XR), digital twins, AI, and related emerging enterprise technology space. B2B Events, Augmented Reality, Virtual Reality, Tech Expo, Mixed Reality, Exoskeletons, Internet of Things (IoT), Enterprise Mobility, Emerging Technology, Metaverse, Spatial Computing, Digital Twins, Artificial Intelligence, Enterprise Technology, Digital Transformation, Future of Work, XR, and Extended Reality Type: | 86 | 0 | 86 | 8 |
 | Stemcentrx, Inc. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates. Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and … Type: | 0 | 0 | 0 | 7 |
 | Aratana Therapeutics Inc. Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets … Type: | 2 | 0 | 0 | 16 |
 | UGECAM PACA et Corse [Automatic translation follows] Treat, re-educate, reintegrate: health without prejudice • UGECAM Group: - 1st non-profit private health operator - involved in the areas of follow-up care and rehabilitation - 225 establishments, 14,500 beds and places, and 13,500 professionals. - 13 regional directorates each managing around twenty health and/or medico-social establishments in France • UGECAM PACA Corsica: - presence in 6 departments - offering quality care, as close as possible to the needs of the population - 6 specialized Post-Care and Rehabilitation (SSR) health establishments - 20 medico-social structures for children and adults with motor and/or mental disabilities - recognized health … Type: | 7 | 2 | 5 | 420 |
 | Biosortia, Inc. - Microbiomics Amplifying rare & unknown metabolites/molecules in natural microbiomes for, AI datasets, for drug & ag discovery starts Selectively Screen Biosortia’s Novel Small Molecules Biosortia is continually expanding the novel library of small molecules (SMs) directly from natural microbiomes. Novel SMs from naturally occurring microbes in microbiomes are biologically preoptimized as the best sources of life science starting points. Activities of these small molecules are grouped in well plates according to machine learning for artificial intelligence prioritization or sorted & organized by initial screening activity potential. Out License Data for Artificial Intelligence & Analytics Biosortia out licenses its exclusive database on … Type: | 1 | 0 | 1 | 9 |
 | Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: | 12 | 0 | 12 | 39 |
 | PCI Synthesis PCI Synthesis is a company based out of NEWBURYPORT, MA, United States. Type: | 2 | 0 | 2 | 5 |
 | Berkeley Lights Accelerate your path to live cell function and recovery Berkeley Lights is a leading functional cell biology company focused on enabling and accelerating the rapid development and commercialization of bio-therapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelectTM chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights … Type: | 7 | 1 | 5 | 51 |
 | Bioharmony Therapeutics At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections. Type: | 0 | 0 | 0 | 1 |
 | OvaScience OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to … Type: | 6 | 0 | 1 | 8 |
 | Synthorx Inc Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a … Type: | 1 | 1 | 0 | 13 |
 | RxGenomix Making personalized healthcare possible for individuals, healthcare providers, benefit administrators and employers. Pharmacogenomics (PGx) is the next frontier in medication therapy management and RxGenomix was created specifically to help put it to work for everyone. RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage. Empowering healthcare providers with … Type: | 2 | 1 | 1 | 13 |
 | Biom'up Innovative Biosurgery Founded in 2005 and based in the Lyon suburb of Saint-Priest (France), Biom’up develops and commercializes hemostatic products based on patented biopolymers designed to simplify traditional and laparoscopic surgical procedures in numerous specialties such as cardiac, general and orthopedic, and give patients a better quality of life. The Company’s lead product, HEMOBLASTTM Bellows, is marketed in Europe and the United States. Biotechnologie, Dispositifs Médicaux Implantables, Collagène, Equipements médicaux, Hémostase, Innovative biosurgery, Medical devices, Hemostasis, Collagen, Biotechnology, Pharmacy, Hemoblast, hemostatic, medical devices, and hemostasis Type: | 1 | 0 | 1 | 37 |
 | Pear Therapeutics The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first … Type: | 13 | 4 | 1 | 36 |
 | ECOVO Project manager within medical device and pharmaceutical industry. Type: | 0 | 0 | 0 | 2 |
 | PlateletBio Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery Type: | 4 | 0 | 4 | 4 |
 | Rheos Medicines [Automatic translation follows] Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our … Type: | 0 | 0 | 0 | 23 |
 | MHW Care [Automatic translation follows] Lumix Laser - Cutting-edge technology - Unique, powerful & versatile Exclusive French distributor for FISIOLINE. Cutting-edge technologies and effective therapeutic protocols for results from the first session. Medical Device, Laser, and Surgery Type: | 1 | 1 | 0 | 1 |
 | CERENOVUS Let's change the TRAJECTORY of stroke TOGETHER CERENOVUS, part of Johnson & Johnson MedTech, is an emerging leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke. Medical Device, MedTech, Medical Technology, Stroke Care, Stroke Treatment, Neurovascular Care, Mechanical Thrombectomy, and Stroke Solutions Type: | 1 | 0 | 1 | 320 |
 | Translate Bio, A Sanofi Company Developing mRNA vaccines and therapeutics In September 2021, Sanofi acquired Translate Bio, a clinical-stage mRNA therapeutics company. This acquisition further accelerates Sanofi’s efforts to develop transformative vaccines and therapies using mRNA technology. It adds a critical pillar to the company’s mRNA Center of Excellence, which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We … Type: | 1 | 0 | 1 | 97 |
 | a:head bio AG we aim to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of … Type: | 1 | 0 | 1 | 19 |
 | Hilleman Laboratories Pvt. Ltd. HILLEMAN LABORATORIES IS COMMITTED TO DEVELOPING HIGH IMPACT, AFFORDABLE VACCINES FOR PEOPLE IN DEVELOPING COUNTRIES. A first-of-its-kind initiative, Hilleman Laboratories is an equal joint-venture partnership formed between Merck & Co., a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to human and animal health. Headquartered in India, Hilleman Laboratories is a not-for-profit organization leveraging a cadre of talented scientists from around the globe. The MSD Wellcome Trust Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner. The work of the Hilleman Laboratories will focus … Type: | 2 | 0 | 2 | 10 |
 | RGL Research Supporting Healthcare Innovation R.G.L Research is a contract research organization (CRO) providing expertise and reliable support to the pharmaceutical industries for conducting Clinical Trials. Our clients and partners include pharmaceuticals, biotechnologies, startups, academic and government organization. R.G.L Research is providing tailored and quality services to help clients and partners bend the cost and time curve of drug development to deliver new alternative product and innovative treatment to improve patients quality of life. R.G.L Research has vast professional experience and academic knowledge in performing clinical trials in Israel as well as developing health product in diverse therapeutic areas of medicine, in … Type: | 0 | 0 | 0 | 0 |
 | PLANTEDIT Our mission is to produce non-transgenic, regulatory free, sustainable, consumer oriented genome edited plant products. PLANTeDIT is the first biotech company dedicated to use patented next generation genome editing tools CRISPR/Cas9 RNPs® from our key collaborator Toolgen (http://toolgen.com/?lang=en) with our transformation technology for efficient direct delivery and swift regeneration of genome edited plants. Our mission is also to revolutionize plant transformation technology with our innovative, universal, cost effective, swift transformation system applicable to broad a range of crop species for direct delivery of genome editing tools. Further, PLANTeDIT aims to develop highly pure mammalian protein and human drugs at cost … Type: | 0 | 0 | 0 | 1 |
 | CrannMed CrannMed is developing resorbable embolization technologies CrannMed was founded in 2018 with the aim of bringing together world-leading clinical, material science and delivery system experts to deliver the benefits of resorbable embolisation to patients worldwide. Permanent microspheres have existed for more than 20 years, and are routinely used to treat liver cancer, uterine fibroids and benign prostate hyperplasia. Resorbable microspheres can be used to treat a range of new indications where it is desirable to restore blood flow to the targeted area after the desired therapeutic effect has been achieved. These resorbable microspheres have new applications in areas such as … Type: | 0 | 0 | 0 | 13 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 4 | 2 | 3 | 62 |
 | Verona Pharma Developing life enhancing treatments for chronic respiratory diseases Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. If successfully developed and approved, Verona Pharma's product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. Ensifentrine met the primary endpoint in both ENHANCE-1 and ENHANCE-2 trials demonstrating statistically significant and clinically meaningful improvements in lung function. In addition, ensifentrine significantly reduced the rate of COPD exacerbations in ENHANCE-1 … Type: | 0 | 0 | 0 | 106 |
 | Eurofins BioPharma Product Testing Italy Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing Type: | 1 | 1 | 0 | 430 |
 | SingCell A stem cells Contract Development and Manufacturing Organisation (CDMO) in Singapore. MSC, iPSC, clean meat. SingCell offers process development and contract manufacturing services for stem cell therapy and clean meat companies. SingCell leverages its proprietary technology to improve manufacturing processes and offer high consistent quality stem cells. #cleanmeat #celltherapy Type: | 0 | 0 | 0 | 2 |
 | Kuur Therapeutics Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors. Immunotherapy, Cancer, Oncology, T cells, TCR, CAR, CAR-NKT, clinical trial, NKT Cells, celltherapy, and lifesciences Type: | 2 | 2 | 0 | 99 |
 | DiscoveryOrtho Partners A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation Type: | 0 | 0 | 0 | 2 |
 | EPSMR [Automatic translation follows] Public Mental Health Establishment of Reunion Island. Ansanm sa minm nout shömin! The Public Mental Health Establishment of Réunion provides prevention, hospitalization and follow-up after hospitalization for patients in the North, West and East health territories of the department (population of the basin concerned: more than 540,000 inhabitants). It has 532 beds and places spread over two full hospitalization sites (Grand Pourpier and Bras Fusil) and around forty other structures including: - 14 day hospitals, - 15 Medical-Psychological Centers, - 3 Part-Time Therapeutic Reception Centers, - 2 Psychiatric Reception Units in general hospitals - 2 Short-Term Hospitalization … Type: | 3 | 1 | 2 | 313 |
 | Medicago La santé est dans notre nature | Health is in our nature. Medicago develops vaccines and treatments to help fight emerging global health challenges, today and in the future. Please note that we may come across a situation not outlined above that will require the removal of your comment. Please know that Medicago reserves the right to delete any comment at its sole discretion. If you feel your comment has been unfairly removed, please contact us. For information about our commenting guidelines, please visit: http://ow.ly/6mKh50HKyUR Medicago développe des vaccins et des traitements pour répondre rapidement aux nouveaux défis de santé … Type: | 3 | 0 | 0 | 180 |
 | Medgadget Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004. Medgadget is an independent publication and is published by a group of MDs and biomed engineers. If you have collaboration ideas or entrepreneurial experience that you want to bring to our company's attention, we want to hear from you. We believe that possibilities at Medgadget are endless! medical devices, medical discoveries, medical technology, conferences, medicine, events, and publishing Type: | 3 | 0 | 0 | 10 |
 | Haag-Streit UK Look closer. See further. Haag-Streit UK, headquartered in Harlow, Essex, is a leading UK provider of diagnostic and surgical equipment for ophthalmologists, optometrists, and orthoptists. It designs, manufactures, and distributes a complete portfolio of medical devices, including; slit lamps, biometers, perimeters, OCT devices, lasers, medical simulators, and microscopes. It also provides a comprehensive range of gold-standard micro-surgical instruments and procedures & implants. HS-UK is the Sole UK Distributor for a number of leading brands, such as; Haag-Streit Diagnostics, Clement Clarke Ophthalmic, John Weiss, Optovue, Meridian, Haag-Streit Simulation, and Haag-Streit Surgical. It is also an Authorised UK Distributor for a number … Type: | 4 | 0 | 4 | 67 |
Startup